/Lists

Biotech Series B Investors & VC Firms

724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.

Sands Capital Ventures
ArlingtonSeed–Late Stage$10M – $30M
187 people
8VC
AustinPre-Seed–Series C$500K – $50M
58 people
OrbiMed
New YorkSeed–Late Stage$1M – $75M
93 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
33 people
In-Q-Tel
TysonsSeed–Growth$100K – $2.5M
35 people
B Capital Group
San FranciscoPre-Seed–Late Stage$10M – $50M
99 people
Madrona Venture Group
SeattlePre-Seed–Series C$2M – $10M
64 people
Venrock
Palo AltoSeed–Late Stage$500K – $10M
69 people
SV Health Investors
LondonSeed–Late Stage$1M – $20M
88 people
Lux Capital
New YorkPre-Seed–Series B$100K – $100M
46 people
HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
89 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
116 people
Blackbird Ventures
SydneyPre-Seed–Series B$149K – $60M
51 people
Capria Ventures
SeattleSeed–Growth$300K – $1M
19 people
Octopus Ventures
LondonPre-Seed–Growth$130K – $1.3M
37 people
Lerer Hippeau
New YorkSeed–Series B$500K – $2M
22 people
Frazier Life Sciences
Palo AltoSeed–Late Stage
77 people
Atlas Venture
CambridgeSeed–Series B$500K – $1M
84 people
Sofinnova Partners
ParisSeed–Late Stage$540K – $27M
79 people
BDC Venture Capital
MontrealPre-Seed–Growth$365K – $25.6M
109 people
JAFCO Group
TokyoPre-Seed–Growth
89 people
Abstract Ventures
San FranciscoPre-Seed–Series C$250K – $750K
6 people
Oak HC/FT
StamfordSeed–Growth
54 people
Korea Investment Partners
SeoulSeed–Series C$3M – $10M
80 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.